Skip to content
Clinical Trials – home

ACEMETACIN: A Comprehensive Guide for Patients with Chronic Back Pain

1 / 2
trials open to patients / all trials
2+
Countries

In short

This article delves into the use of Acemetacin, a medication being studied in clinical trials for its potential in treating chronic back pain. We'll examine a specific trial that aims to evaluate the effectiveness and tolerability of Acemetacin as an add-on treatment for patients suffering from this condition. The study focuses on assessing pain reduction, quality of life improvements, and safety aspects of the drug.

At a glance

Study Drug
Acemetacin (AP707)
Condition Studied
Chronic back pain
Main Objective
Evaluate efficacy of Acemetacin as add-on treatment
Study Duration
Up to 52 weeks
Primary Endpoint
Change in pain level at 14 weeks
Key Inclusion Criteria
Adults with chronic back pain for at least 3 months, pain intensity >5 on NRS
Key Exclusion Criteria
History of severe cardiovascular disease, mental illness, or addictive disease
Safety Measures
Monitoring of adverse events, liver and kidney function tests
Secondary Outcomes
Changes in quality of life, sleep quality, psychological distress

What is ACEMETACIN?

ACEMETACIN is a medication that belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used to treat pain and inflammation in various conditions, particularly chronic back pain. ACEMETACIN is the active substance in this medication, which means it's the component responsible for the drug's effects in your body.

Medical Conditions Treated

The primary medical condition that ACEMETACIN is being studied for is chronic back pain. Chronic back pain is defined as pain in the back that persists for 3 months or longer. This type of pain can significantly impact a person's quality of life, affecting their ability to work, sleep, and perform daily activities.

How ACEMETACIN Works

As an NSAID, ACEMETACIN works by reducing inflammation in the body. It does this by inhibiting certain enzymes that are responsible for producing substances that cause pain and inflammation. By reducing inflammation, ACEMETACIN can help alleviate pain and improve mobility for people suffering from chronic back pain.

Dosage and Administration

ACEMETACIN is typically taken orally, meaning it's swallowed as a tablet or capsule. The maximum daily dose of ACEMETACIN is 300 mg. However, it's important to note that the exact dosage may vary depending on individual factors such as the severity of your condition and your overall health. Always follow your doctor's instructions regarding dosage and administration.

Eligibility for Treatment

Not everyone with chronic back pain may be eligible for ACEMETACIN treatment. Based on ongoing research, here are some factors that may determine eligibility:

  • You must be 18 years or older.
  • You should have been experiencing chronic back pain for at least 3 months.
  • Your pain should be moderate to severe, with a pain intensity greater than 5 on a scale of 0-10.
  • You should not have a history of severe cardiovascular disease, mental illness, or addictive disorders.
  • You should not have severe liver or kidney diseases.

Potential Side Effects and Precautions

As with all medications, ACEMETACIN may cause side effects. Some potential concerns include:

  • Cardiovascular risks: People with a history of severe cardiovascular disease should use caution.
  • Liver and kidney effects: ACEMETACIN may affect liver and kidney function. Regular monitoring of these organs may be necessary.
  • Gastrointestinal effects: As with many NSAIDs, ACEMETACIN may cause stomach upset or other digestive issues.

It's important to discuss any pre-existing conditions or medications you're taking with your healthcare provider before starting ACEMETACIN treatment.

Ongoing Research

ACEMETACIN is currently being studied in clinical trials to further evaluate its effectiveness and safety in treating chronic back pain. These studies are looking at various aspects, including:

  • How well ACEMETACIN reduces pain levels over different time periods (14 weeks, 26 weeks, and 52 weeks).
  • Its impact on quality of life, sleep quality, and psychological distress in patients with chronic back pain.
  • The number and severity of side effects that occur during treatment.

These ongoing studies will provide more information about the long-term effectiveness and safety of ACEMETACIN in treating chronic back pain.

Questions people often ask

Conditions where Acemetacin is being studied

Each condition opens its own overview and trial list

Trials with Acemetacin

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.